It was demonstrated that hydralazine induces DNA demethylation, decreases DNMT activity and promotes RARβ, p21, p16 and APC gene expression in breast, bladder and cervical cancer cell lines, respectively [24,25,26]. Here, DNMT1 is linked to cervical carcinoma.